STOCK TITAN

SOFGEN PHARMA S.A WTS (PRCWF) Revenue by Year

PRCWF

SOFGEN PHARMA S.A WTS generated $373.8M in revenue in fiscal year 2024. This represents a decrease of 11.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters SOFGEN PHARMA S.A WTS has filed alongside them.

FY2024 annual
Revenue $373.8M
YoY -11.8%
5Y CAGR +2.9%
Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PRCWF Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Revenue$373.8M-11.8%$423.7M+5.1%$403.2M-0.1%$403.7M+21.8%$331.5M+2.1%$324.8M

PRCWF Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2410-KQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-QQ4'2110-KQ4'2010-KQ4'1910-KQ4'1810-K
RevenueN/AN/A$110.1M-2.1%N/A$112.4MN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More SOFGEN PHARMA S.A WTS financials

Frequently Asked Questions

What was SOFGEN PHARMA S.A WTS's revenue in fiscal year 2024?

SOFGEN PHARMA S.A WTS generated $373.8M in revenue in fiscal year 2024.

How fast is SOFGEN PHARMA S.A WTS's revenue growing?

SOFGEN PHARMA S.A WTS (PRCWF) revenue fell by 11.8% year over year, from $423.7M to $373.8M in fiscal year 2024.

How has SOFGEN PHARMA S.A WTS's revenue changed over the years?

Across the 6 fiscal years this page covers, SOFGEN PHARMA S.A WTS (PRCWF) revenue went from $324.8M in fiscal year 2019 to $373.8M in fiscal year 2024.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what SOFGEN PHARMA S.A WTS (PRCWF) reported on that line in every period on record.